<DOC>
	<DOCNO>NCT00888576</DOCNO>
	<brief_summary>The purpose study develop registry safety efficacy data use etanercept clinical practice Taiwan .</brief_summary>
	<brief_title>Registry Etanercept Use Patients With Rheumatoid Arthritis Clinical Practice Taiwan</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Main 1 ) Male female patient age &gt; 20 year ; 2 ) Patients already select approve Taiwan National Health Insurance Program receive 24 week etanercept rheumatoid arthritis . Main None</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>